News
BPL-003 showed “robust” efficacy data in treatment-resistant depression, according to analysts from Jefferies, who noted that ...
Atai Life Sciences NV shares climbed after a psychedelic nasal spray from Beckley Psytech Ltd, the company it plans to ...
ARS Pharma has claimed FDA approval for its epinephrine nasal spray neffy, becoming the first needle-free alternative to EpiPen-style autoinjectors for serious allergic reactions. The green light ...
Premature babies often need help breathing as their lungs are not fully developed. Nasal breathing support (through the nose) helps premature babies breathe without the need for breathing tubes in the ...
In simpler terms, the particles, which were invented by researchers at The Chinese University of Hong Kong, contain a mix of the elements bismuth, oxygen and iodine along with the ... damage to ...
Positive study results in Phase 2 lead to a green light for the companies’ combination and plans to move their nasal spray ...
1d
Clinical Trials Arena on MSNatai and Beckley Psytech’s psychedelic wins in Phase IIb depression trialThe companies are also running an open-label study to evaluate the long-term efficacy and safety of the therapy.
STS101 nasal powder, DHE, delivers fast, lasting relief from cardinal migraine symptoms, including photophobia, phonophobia, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results